How To Tell If Immunotherapy Is Working? Key Facts

Immunotherapy has changed how many cancers are treated, but it works differently than chemotherapy. You cannot always tell if it is working by how you feel. The only way doctors confirm that immunotherapy is working is through imaging scans, biopsies, and blood tests taken at specific intervals. Feeling better is a good sign, but it is not proof, and feeling worse does not always mean the treatment is failing.

How Do Doctors Measure Immunotherapy Response?

Doctors use a set of standard tools to measure whether immunotherapy is working. The most common method is imaging, such as CT, MRI, or PET scans. These scans show the size and location of tumors. Doctors compare scans taken before treatment with scans taken during treatment to see if tumors are shrinking, stable, or growing.

Response is usually classified into a few categories. A complete response means no cancer is visible on scans. A partial response means tumors have shrunk by a measurable amount. Stable disease means tumors have not grown or shrunk significantly. Progressive disease means tumors have grown or new tumors have appeared.

These categories are based on specific criteria that oncologists use worldwide. The criteria define how much change counts as a response. A small change on a scan may not qualify as a partial response. Doctors look for meaningful changes, not minor fluctuations.

Blood tests also play a role. Some cancers release proteins into the blood that can be measured. A drop in these tumor markers can suggest the treatment is working. But not all cancers have reliable markers. Normal blood counts and organ function tests also matter because they show how well the body is tolerating treatment.

When Is the First Response Check?

The first response check usually happens about 8 to 12 weeks after treatment starts. This timing is not random. It takes time for the immune system to recognize cancer cells and mount an attack. Checking too early could show no change even when the treatment will eventually work.

Some patients respond quickly. Others take several cycles before any change appears on scans. Your oncologist will schedule scans based on the specific type of cancer, the drug being used, and your overall health.

It is important to understand that no response on the first scan does not mean the treatment has failed. Many patients show a response only after several months of treatment. Doctors often continue treatment even when the first scan shows stable disease, because stable disease can be a meaningful outcome in itself.

Can You Feel Immunotherapy Working?

Some patients report feeling better during immunotherapy. They have more energy, better appetite, or less pain. This can happen when tumors shrink and stop pressing on organs or nerves. Feeling better is encouraging, but it is not a reliable measure of response.

Other patients feel worse before they feel better. Immunotherapy can cause side effects that feel like the flu, including fever, chills, fatigue, and muscle aches. These side effects are a sign that the immune system is activated. They do not tell you whether the immune system is attacking cancer cells effectively.

Some patients feel no different at all and still have a strong response. The absence of symptoms is not evidence that treatment is failing. The reverse is also true. Feeling unwell does not mean treatment is working. Symptoms and side effects do not predict the outcome of immunotherapy with any accuracy.

What Is Pseudoprogression?

Pseudoprogression is one of the most confusing parts of immunotherapy. It happens when tumors appear to grow on a scan, but the growth is actually caused by immune cells flooding into the tumor. The tumor may look bigger or new spots may appear, but the treatment is working.

This is not a rare event, but it is not the most common outcome either. Some studies suggest pseudoprogression occurs in a small percentage of patients, particularly with certain types of immunotherapy drugs called checkpoint inhibitors. The exact rate varies by cancer type and drug.

Doctors cannot always tell the difference between real tumor growth and pseudoprogression on a single scan. In some cases, they may recommend a biopsy of the lesion. A biopsy can show whether the tissue contains mostly cancer cells or mostly immune cells.

If pseudoprogression is suspected, doctors usually continue treatment and repeat the scan a few weeks later. If the scan shows the tumor shrinking, the earlier growth was likely pseudoprogression. This is why it is critical not to stop immunotherapy based on one scan alone without discussing it with your oncologist.

Why Do Some Tumors Grow Before They Shrink?

Immunotherapy works by removing the brakes on the immune system. Cancer cells often find ways to hide from immune cells or turn them off. Checkpoint inhibitors block these hiding mechanisms, allowing T cells to attack the cancer.

When T cells first enter a tumor, they cause inflammation. This inflammation can make the tumor appear larger on a scan. The tumor is not actually growing. It is swelling with immune activity. This swelling can take weeks to resolve.

This immune response is different from chemotherapy, which kills dividing cells directly. Chemotherapy effects are often visible sooner. Immunotherapy effects take longer to show up on scans because they depend on the body building an immune response. This delay is normal and expected.

What If Immunotherapy Does Not Work?

Some patients do not respond to immunotherapy at all. Their tumors continue to grow despite treatment. This is called primary resistance. In other cases, patients respond initially but later the cancer starts growing again. This is called acquired resistance.

When scans show clear tumor growth, doctors usually stop immunotherapy. Continuing a treatment that is not working exposes you to side effects without benefit. Your oncologist may switch to a different treatment, such as chemotherapy, targeted therapy, or a clinical trial.

It is also possible to have mixed responses. Some tumors shrink while others grow. This can happen when tumors have different genetic features. Doctors evaluate the overall pattern to decide whether to continue, change, or stop treatment.

No blood test or symptom can tell you with certainty that immunotherapy is failing. The evidence comes from imaging and clinical evaluation. If you have concerns about how treatment is going, ask your oncologist directly what the scans show and what the plan is.

How Long Does Immunotherapy Keep Working?

Some patients remain on immunotherapy for years. Others stop after a complete response. The duration of treatment depends on the specific drug, the cancer type, and how well you tolerate the treatment.

Some immunotherapy drugs are given for a fixed period, such as two years. Others are continued as long as the cancer remains controlled and side effects are manageable. Your oncologist will discuss the planned treatment duration before you start.

In some cases, patients who achieve a complete response can stop treatment early. Studies have shown that some patients maintain their response after stopping. This is not true for everyone, and the decision to stop is made carefully with your oncology team.

What Side Effects Should You Report?

Immunotherapy side effects are different from chemotherapy side effects. They happen when the immune system becomes overactive and attacks healthy tissue. This is called an immune-related adverse event.

These side effects can affect any organ. Common ones include skin rash, diarrhea, and inflammation of the lungs, liver, or thyroid. Some side effects are mild and manageable. Others can be serious and require stopping treatment temporarily or permanently.

Report any new symptom to your oncology team promptly. Early treatment of immune-related side effects is important. Corticosteroids can often control these side effects, but they are most effective when started early.

Do not stop immunotherapy on your own if you develop side effects. Your doctor needs to determine whether the side effect is related to treatment and how to manage it. Stopping suddenly can affect the treatment outcome.

What Questions Should You Ask Your Oncologist?

Before each scan, ask what the scan will show and what changes would be meaningful. After the scan, ask for a clear explanation of the results. You have the right to understand what the images show in plain language.

Useful questions include:

• Has the tumor grown, shrunk, or stayed the same?
• What does this scan mean compared to the last one?
• Are there any new spots that need attention?
• When is the next scan scheduled?
• What would make us stop or change this treatment?

Write down your questions before appointments. Bring someone with you to take notes. The information can be complex, and having a second set of ears helps.